Market Tracker

10/20 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.41
Delayed Data
As of Oct 20
 -0.09 / -1.38%
Today’s Change
4.60
Today|||52-Week Range
11.72
-25.81%
Year-to-Date
3 Biotech Values in a Fully Valued Market
Oct 15 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close6.50
Today’s open6.54
Day’s range6.29 - 6.54
Volume892,531
Average volume (3 months)1,013,665
Market cap$450.4M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-700.00%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+700.24%
P/E ratioNM
Price/Sales8.73
Price/Book4.29

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...-0.16-0.82%
ASMBAssembly Biosciences...+0.35+1.13%
CARACara Therapeutics In...+0.06+0.49%
KPTIKaryopharm Therapeut...-0.04-0.36%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
Tarrytown, New York

Forecasts